Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies.

导出 OA

翻译打印收藏纠错

作者： Roman,Groisberg ^[1] ; Jason,Roszik ^[2] ; Anthony P,Conley ^[3] ; Alexander J,Lazar ^[4] ; Daniella E,Portal ^[1] ; David S,Hong ^[5] ; Aung,Naing ^[5] ; Cynthia E,Herzog ^[6] ; Neeta,Somaiah ^[3] ; Maria A,Zarzour ^[3] ; Shreyaskumar,Patel ^[3] ; Robert E,Brown ^[7] ; Vivek,Subbiah ^[8]

作者单位： Department of Melanoma/Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. ^[1] Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[2] Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[3] Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[4] Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[5] Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[6] Department of Pathology and Laboratory Medicine, UTHealth McGovern Medical School, Houston, Texas. ^[7] Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. vsubbiah@mdanderson.org. ^[8]